Freedom Investment Management, Inc. - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 58 filers reported holding GALECTIN THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 63.58 and the average weighting 0.0%.

Quarter-by-quarter ownership
Freedom Investment Management, Inc. ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q1 2016$54,000
-28.0%
37,557
-18.2%
0.00%
-33.3%
Q4 2015$75,000
-91.0%
45,902
+392.2%
0.01%
-92.9%
Q3 2015$832,000
+565.6%
9,325
-79.6%
0.08%
+553.8%
Q2 2015$125,000
-24.2%
45,723
-7.4%
0.01%
-27.8%
Q1 2015$165,000
-14.5%
49,391
-11.4%
0.02%
-28.0%
Q4 2014$193,000
+135.4%
55,719
+241.3%
0.02%
+78.6%
Q3 2014$82,000
-61.9%
16,324
+5.0%
0.01%
-61.1%
Q2 2014$215,000
-7.3%
15,543
+2.8%
0.04%
-28.0%
Q1 2014$232,000
+123.1%
15,124
+17.0%
0.05%
+92.3%
Q4 2013$104,000
-12.6%
12,921
+8.2%
0.03%
-23.5%
Q3 2013$119,00011,9390.03%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 129,488$248,6170.07%
Geneos Wealth Management Inc. 417,350$801,3120.04%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$23,0400.02%
RETIREMENT GUYS FORMULA LLC 11,500$22,0800.02%
Vivaldi Capital Management LP 19,261$36,9810.01%
OSAIC HOLDINGS, INC. 3,275,192$6,288,3450.01%
Traynor Capital Management, Inc. 34,707$66,6380.01%
Atria Wealth Solutions, Inc. 259,800$498,8160.01%
BARRETT & COMPANY, INC. 4,984$9,5690.01%
Wealthspire Advisors, LLC 183,862$353,0160.01%
View complete list of GALECTIN THERAPEUTICS INC shareholders